Ansto has appointed US-based consultants JacobsWyper to consider financial, manufacturing and import options to secure the long-term sustainability of the supply of nuclear medicine in Australia.

The move follows granting of federal funding to support the development of a business case for the nuclear medicine sector.

Ansto said the purpose of the exercise with JacobsWyper is to help the Ansto board decide on a supply model to recommend to the government.